Redox regulation of FoxO transcription factors

Redox Biology

Volumn 6, Issue , 2015, Pages 51-72

  Klotz, Lars Oliver ^a   Sánchez Ramos, Cristina ^b   Prieto Arroyo, Ignacio ^b   Urbánek, Pavel ^a   Steinbrenner, Holger ^a   Monsalve, Maria ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

Akt; Antioxidant proteins; C. elegans; DAF 16; Forkhead box proteins; Insulin signaling; Oxidative stress; Stress signaling

Indexed keywords

REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FOXO; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; ISOPROTEIN; MITOCHONDRIAL PROTEIN; PLASMA PROTEIN; TRANSCRIPTION FACTOR FKHR;

ACETYLATION; ADIPOCYTE; BLOOD; BONE; BONE TISSUE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; FOXO GENE; GENE TARGETING; GENETIC CODE; HUMAN; KIDNEY; LIVER; MALIGNANT NEOPLASTIC DISEASE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATOR GENE; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SKIN; TRANSCRIPTION REGULATION; UBIQUITINATION; AMINO ACID SEQUENCE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NEOPLASM; OXIDATION REDUCTION REACTION; PATHOLOGY; PROTEIN TERTIARY STRUCTURE;

CAENORHABDITIS ELEGANS;

AMINO ACID SEQUENCE; BLOOD PROTEINS; DIABETES MELLITUS, TYPE 2; FORKHEAD BOX PROTEIN O1; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; MITOCHONDRIAL PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASMS; OBESITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84936946288     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.06.019     Document Type: Review

References (333)

1. Weigel D., Jürgens G., Küttner F., Seifert E., Jäckle H. The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 1989, 57:645-658.
2. Weigel D., Jäckle H. The fork head domain: a novel DNA binding motif of eukaryotic transcription factors?. Cell 1990, 63:455-456.
3. Kaestner K.H., Knochel W., Martinez D.E. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 2000, 14:142-146.
4. Kenyon C. The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2011, 366:9-16.
5. Kenyon C., Chang J., Gensch E., Rudner A., Tabtiang R.A. C. elegans mutant that lives twice as long as wild type. Nature 1993, 366:461-464.
6. Ogg S., Paradis S., Gottlieb S., Patterson G.I., Lee L., Tissenbaum H.A., Ruvkun G. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 1997, 389:994-999.
7. Lin K., Dorman J.B., Rodan A., Kenyon C. daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 1997, 278:1319-1322.
8. Kimura K.D., Tissenbaum H.A., Liu Y., Ruvkun G. daf-2, An insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 1997, 277:942-946.
9. Honda Y., Honda S. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB J. 1999, 13:1385-1393.
10. Honda Y., Honda S. Oxidative stress and life span determination in the nematode Caenorhabditis elegans. Ann. N.Y. Acad. Sci. 2002, 959:466-474.
11. Kops G.J., Dansen T.B., Polderman P.E., Saarloos I., Wirtz K.W., Coffer P.J., Huang T.T., Bos J.L., Medema R.H., Burgering B.M. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002, 419:316-321.
12. Doonan R., McElwee J.J., Matthijssens F., Walker G.A., Houthoofd K., Back P., Matscheski A., Vanfleteren J.R., Gems D. Against the oxidative damage theory of aging: superoxide dismutases protect against oxidative stress but have little or no effect on life span in Caenorhabditis elegans. Genes Dev. 2008, 22:3236-3241.
13. Greer E.L., Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 2005, 24:7410-7425.
14. Monsalve M., Olmos Y. The complex biology of FOXO. Curr. Drug Targets 2011, 12:1322-1350.
15. Kim D.H., Perdomo G., Zhang T., Slusher S., Lee S., Phillips B.E., Fan Y., Giannoukakis N., Gramignoli R., Strom S., Ringquist S., Dong H.H. FoxO6 integrates insulin signaling with gluconeogenesis in the liver. Diabetes 2011, 60:2763-2774.
16. Calnan D.R., Brunet A. The FoxO code. Oncogene 2008, 27:2276-2288.
17. Marinkovic D., Zhang X., Yalcin S., Luciano J.P., Brugnara C., Huber T., Ghaffari S. Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J. Clin. Investig. 2007, 117:2133-2144.
18. Nemoto S., Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002, 295:2450-2452.
19. Chiribau C.B., Cheng L., Cucoranu I.C., Yu Y.S., Clempus R.E., Sorescu D. FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts. J. Biol. Chem. 2008, 283:8211-8217.
20. Olmos Y., Sanchez-Gomez F.J., Wild B., Garcia-Quintans N., Cabezudo S., Lamas S., Monsalve M. SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC-1alpha complex. Antioxid. Redox Signal. 2013, 19:1507-1521.
21. Barsyte D., Lovejoy D.A., Lithgow G.J. Longevity and heavy metal resistance in daf-2 and age-1 long-lived mutants of Caenorhabditis elegans. FASEB J. 2001, 15:627-634.
22. Anderson C.P., Leibold E.A. Mechanisms of iron metabolism in Caenorhabditis elegans. Front. Pharmacol. 2014, 5:113.
23. Greer E.L., Oskoui P.R., Banko M.R., Maniar J.M., Gygi M.P., Gygi S.P., Brunet A. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem. 2007, 282:30107-30119.
24. Leyendecker M., Korsten P., Reinehr R., Speckmann B., Schmoll D., Scherbaum W.A., Bornstein S.R., Barthel A., Klotz L.O. Ceruloplasmin expression in rat liver cells is attenuated by insulin: role of FoxO transcription factors. Horm. Metab. Res. 2011, 43:268-274.
25. Sidhu A., Miller P.J., Hollenbach A.D. FOXO1 stimulates ceruloplasmin promoter activity in human hepatoma cells treated with IL-6. Biochem. Biophys. Res. Commun. 2011, 404:963-967.
26. Hellman N.E., Gitlin J.D. Ceruloplasmin metabolism and function. Annu. Rev. Nutr. 2002, 22:439-458.
27. White K.N., Conesa C., Sanchez L., Amini M., Farnaud S., Lorvoralak C., Evans R.W. The transfer of iron between ceruloplasmin and transferrins. Biochim. Biophys. Acta 2012, 1820:411-416.
28. Walter P.L., Steinbrenner H., Barthel A., Klotz L.O. Stimulation of selenoprotein P promoter activity in hepatoma cells by FoxO1a transcription factor. Biochem. Biophys. Res. Commun. 2008, 365:316-321.
29. Speckmann B., Walter P.L., Alili L., Reinehr R., Sies H., Klotz L.O., Steinbrenner H. Selenoprotein P expression is controlled through interaction of the coactivator PGC-1alpha with FoxO1a and hepatocyte nuclear factor 4alpha transcription factors. Hepatology 2008, 48:1998-2006.
30. Saito Y., Hayashi T., Tanaka A., Watanabe Y., Suzuki M., Saito E., Takahashi K. Selenoprotein P in human plasma as an extracellular phospholipid hydroperoxide glutathione peroxidase. Isolation and enzymatic characterization of human selenoprotein p. J. Biol. Chem. 1999, 274:2866-2871.
31. Takebe G., Yarimizu J., Saito Y., Hayashi T., Nakamura H., Yodoi J., Nagasawa S., Takahashi K. A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P. J. Biol. Chem. 2002, 277:41254-41258.
32. Traulsen H., Steinbrenner H., Buchczyk D.P., Klotz L.O., Sies H. Selenoprotein P protects low-density lipoprotein against oxidation. Free Radic. Res. 2004, 38:123-128.
33. Burk R.F., Hill K.E., Selenoprotein P. An extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu. Rev. Nutr. 2005, 25:215-235.
34. Hoffmann P.R., Hoge S.C., Li P.A., Hoffmann F.W., Hashimoto A.C., Berry M.J. The selenoproteome exhibits widely varying, tissue-specific dependence on selenoprotein P for selenium supply. Nucleic Acids Res. 2007, 35:3963-3973.
35. Steinbrenner H., Alili L., Bilgic E., Sies H., Brenneisen P. Involvement of selenoprotein P in protection of human astrocytes from oxidative damage. Free Radic. Biol. Med. 2006, 40:1513-1523.
36. Steinbrenner H., Bilgic E., Alili L., Sies H., Brenneisen P. Selenoprotein P protects endothelial cells from oxidative damage by stimulation of glutathione peroxidase expression and activity. Free Radic. Res. 2006, 40:936-943.
37. Zhao Y., Wang Y., Zhu W.G. Applications of post-translational modifications of FoxO family proteins in biological functions. J. Mol. Cell. Biol. 2011, 3:276-282.
38. May J.M., de Haen C. Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J. Biol. Chem. 1979, 254:2214-2220.
39. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., Rhee S.G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 1997, 272:217-221.
40. DeYulia G.J., Carcamo J.M. EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFR-associated protein tyrosine phosphatases. Biochem. Biophys. Res. Commun. 2005, 334:38-42.
41. 2 for platelet-derived growth factor signal transduction. Science 1995, 270:296-299.
42. Chen K., Kirber M.T., Xiao H., Yang Y., Keaney J.F. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J. Cell Biol. 2008, 181:1129-1139.
43. Mahadev K., Wu X., Zilbering A., Zhu L., Lawrence J.T., Goldstein B.J. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J. Biol. Chem. 2001, 276:48662-48669.
44. Mahadev K., Zilbering A., Zhu L., Goldstein B.J. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J. Biol. Chem. 2001, 276:21938-21942.
45. Meng T.C., Buckley D.A., Galic S., Tiganis T., Tonks N.K. Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B. J. Biol. Chem. 2004, 279:37716-37725.
46. 2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 2004, 24:1844-1854.
47. Katsuyama M., Matsuno K., Yabe-Nishimura C. Physiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme. J. Clin. Biochem. Nutr. 2012, 50:9-22.
48. Schulz E., Wenzel P., Munzel T., Daiber A. Mitochondrial redox signaling: interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. Antioxid. Redox Signal. 2014, 20:308-324.
49. Lassegue B., San Martin A., Griendling K.K. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ. Res. 2012, 110:1364-1390.
50. Schröder K., Wandzioch K., Helmcke I., Brandes R.P. Nox4 acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler. Thromb. Vasc. Biol. 2009, 29:239-245.
51. Wancket L.M., Frazier W.J., Liu Y. Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease. Life Sci. 2012, 90:237-248.
52. 2. Role in cell survival following oxidant injury. J. Biol. Chem. 1996, 271:4138-4142.
53. Wang X., McCullough K.D., Franke T.F., Holbrook N.J. Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J. Biol. Chem. 2000, 275:14624-14631.
54. Schieke S.M., von Montfort C., Buchczyk D.P., Timmer A., Grether-Beck S., Krutmann J., Holbrook N.J., Klotz L.O. Singlet oxygen-induced attenuation of growth factor signaling: possible role of ceramides. Free Radic. Res. 2004, 38:729-737.
55. Schieke S.M., Briviba K., Klotz L.O., Sies H. Activation pattern of mitogen-activated protein kinases elicited by peroxynitrite: attenuation by selenite supplementation. FEBS Lett. 1999, 448:301-303.
56. Klotz L.O., Schieke S.M., Sies H., Holbrook N.J. Peroxynitrite activates the phosphoinositide 3-kinase/Akt pathway in human skin primary fibroblasts. Biochem. J. 2000, 352(Pt 1):219-225.
57. Derijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., Karin M., Davis R.J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994, 76:1025-1037.
58. Sachsenmaier C., Radler-Pohl A., Zinck R., Nordheim A., Herrlich P., Rahmsdorf H.J. Involvement of growth factor receptors in the mammalian UVC response. Cell 1994, 78:963-972.
59. Klotz L.O., Holbrook N.J., Sies H. UVA and singlet oxygen as inducers of cutaneous signaling events. Curr. Probl. Dermatol. 2001, 29:95-113.
60. Klotz L.O., Briviba K., Sies H. Singlet oxygen mediates the activation of JNK by UVA radiation in human skin fibroblasts. FEBS Lett. 1997, 408:289-291.
61. Klotz L.O., Pellieux C., Briviba K., Pierlot C., Aubry J.M., Sies H. Mitogen-activated protein kinase (p38-, JNK-, ERK-) activation pattern induced by extracellular and intracellular singlet oxygen and UVA. Eur. J. Biochem. 1999, 260:917-922.
62. Wang X., Martindale J.L., Liu Y., Holbrook N.J. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J. 1998, 333:291-300.
63. Schmoll D., Walker K.S., Alessi D.R., Grempler R., Burchell A., Guo S., Walther R., Unterman T.G. Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J. Biol. Chem. 2000, 275:36324-36333.
64. Barthel A., Schmoll D., Unterman T.G. FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab. 2005, 16:183-189.
65. Yang J.Y., Zong C.S., Xia W., Yamaguchi H., Ding Q., Xie X., Lang J.Y., Lai C.C., Chang C.J., Huang W.C., Huang H., Kuo H.P., Lee D.F., Li L.Y., Lien H.C., Cheng X., Chang K.J., Hsiao C.D., Tsai F.J., Tsai C.H., Sahin A.A., Muller W.J., Mills G.B., Yu D., Hortobagyi G.N., Hung M.C. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat. Cell Biol. 2008, 10:138-148.
66. Asada S., Daitoku H., Matsuzaki H., Saito T., Sudo T., Mukai H., Iwashita S., Kako K., Kishi T., Kasuya Y., Fukamizu A. Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell Signal. 2007, 19:519-527.
67. Ott C., Jacobs K., Haucke E., Navarrete Santos A., Grune T., Simm A. Role of advanced glycation end products in cellular signaling. Redox Biol. 2014, 2:411-429.
68. Tanaka J., Qiang L., Banks A.S., Welch C.L., Matsumoto M., Kitamura T., Ido-Kitamura Y., DePinho R.A., Accili D. Foxo1 links hyperglycemia to LDL oxidation and endothelial nitric oxide synthase dysfunction in vascular endothelial cells. Diabetes 2009, 58:2344-2354.
69. Yeldandi A.V., Rao M.S., Reddy J.K. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat. Res. 2000, 448:159-177.
70. Lodhi I.J., Semenkovich C.F. Peroxisomes: a nexus for lipid metabolism and cellular signaling. Cell Metab. 2014, 19:380-392.
71. Nordgren M., Fransen M. Peroxisomal metabolism and oxidative stress. Biochimie 2014, 98:56-62.
72. Klotz L.O. Oxidative stress, antioxidants, and chemoprevention: on the role of oxidant-induced signaling in cellular adaptation. Recent Advances in Redox Active Plant and Microbial Products 2014, 119-146. Springer, Dordrecht. C. Jacob, G. Kirsch, A.J. Slusarenko, P.G. Winyard, T. Burkholz (Eds.).
73. Klotz L.O., Hou X., Jacob C. 1,4-Naphthoquinones: from oxidative damage to cellular and inter-cellular signaling. Molecules 2014, 19:14902-14918.
74. Beier J.I., von Montfort C., Sies H., Klotz L.O. Activation of ErbB2 by 2-methyl-1,4-naphthoquinone (menadione) in human keratinocytes: role of EGFR and protein tyrosine phosphatases. FEBS Lett. 2006, 580:1859-1864.
75. Klaus V., Hartmann T., Gambini J., Graf P., Stahl W., Hartwig A., Klotz L.O. 1,4-Naphthoquinones as inducers of oxidative damage and stress signaling in HaCaT human keratinocytes. Arch. Biochem. Biophys. 2010, 496:93-100.
76. Zhang S., Liu X., Bawa-Khalfe T., Lu L.S., Lyu Y.L., Liu L.F., Yeh E.T. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat. Med. 2012, 18:1639-1642.
77. Abdelmohsen K., von Montfort C., Stuhlmann D., Gerber P.A., Decking U.K., Sies H., Klotz L.O. Doxorubicin induces EGF receptor-dependent downregulation of gap junctional intercellular communication in rat liver epithelial cells. Biol. Chem. 2005, 386:217-223.
78. Ho K.K., McGuire V.A., Koo C.Y., Muir K.W., de Olano N., Maifoshie E., Kelly D.J., McGovern U.B., Monteiro L.J., Gomes A.R., Nebreda A.R., Campbell D.G., Arthur J.S., Lam E.W. Phosphorylation of FOXO3a on Ser-7 by p38 promotes its nuclear localization in response to doxorubicin. J. Biol. Chem. 2012, 287:1545-1555.
79. Kavazis A.N., Smuder A.J., Powers S.K. Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle. J. Appl. Physiol. 2014, 117:223-230.
80. Ostrakhovitch E.A., Lordnejad M.R., Schliess F., Sies H., Klotz L.O. Copper ions strongly activate the phosphoinositide-3-kinase/Akt pathway independent of the generation of reactive oxygen species. Arch. Biochem. Biophys. 2002, 397:232-239.
81. Walter P.L., Kampkötter A., Eckers A., Barthel A., Schmoll D., Sies H., Klotz L.O. Modulation of FoxO signaling in human hepatoma cells by exposure to copper or zinc ions. Arch. Biochem. Biophys. 2006, 454:107-113.
82. Barthel A., Ostrakhovitch E.A., Walter P.L., Kampkötter A., Klotz L.O. Stimulation of phosphoinositide 3-kinase/Akt signaling by copper and zinc ions: mechanisms and consequences. Arch. Biochem. Biophys. 2007, 463:175-182.
83. Eckers A., Reimann K., Klotz L.O. Nickel and copper ion-induced stress signaling in human hepatoma cells: analysis of phosphoinositide 3'-kinase/Akt signaling. Biometals 2009, 22:307-316.
84. Plum L.M., Brieger A., Engelhardt G., Hebel S., Nessel A., Arlt M., Kaltenberg J., Schwaneberg U., Huber M., Rink L., Haase H. PTEN-inhibition by zinc ions augments interleukin-2-mediated Akt phosphorylation. Metallomics 2014.
85. Jomova K., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283:65-87.
86. Schwerdtle T., Walter I., Mackiw I., Hartwig A. Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis 2003, 24:967-974.
87. Cai B., Xia Z. p38 MAP kinase mediates arsenite-induced apoptosis through FOXO3a activation and induction of Bim transcription. Apoptosis 2008, 13:803-810.
88. Hamann I., Klotz L.O. Arsenite-induced stress signaling: Modulation of the phosphoinositide 3'-kinase/Akt/FoxO signaling cascade. Redox Biol. 2013, 1:104-109.
89. Hamann I., Petroll K., Hou X., Anwar-Mohamed A., El-Kadi A.O., Klotz L.O. Acute and long-term effects of arsenite in HepG2 cells: modulation of insulin signaling. Biometals 2014, 27:317-332.
90. Long L.H., Lan A.N., Hsuan F.T., Halliwell B. Generation of hydrogen peroxide by "antioxidant" beverages and the effect of milk addition. Is cocoa the best beverage?. Free Radic. Res. 1999, 31:67-71.
91. Long L.H., Clement M.V., Halliwell B. Artifacts in cell culture: rapid generation of hydrogen peroxide on addition of (-)-epigallocatechin, (-)-epigallocatechin gallate, (+)-catechin, and quercetin to commonly used cell culture media. Biochem. Biophys. Res. Commun. 2000, 273:50-53.
92. Bartholome A., Kampkötter A., Tanner S., Sies H., Klotz L.O. Epigallocatechin gallate-induced modulation of FoxO signaling in mammalian cells and C. elegans: FoxO stimulation is masked via PI3K/Akt activation by hydrogen peroxide formed in cell culture. Arch. Biochem. Biophys. 2010, 501:58-64.
93. Essers M.A., Weijzen S., de Vries-Smits A.M., Saarloos I., de Ruiter N.D., Bos J.L., Burgering B.M. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 2004, 23:4802-4812.
94. Huang H., Regan K.M., Lou Z., Chen J., Tindall D.J. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 2006, 314:294-297.
95. Huo X., Liu S., Shao T., Hua H., Kong Q., Wang J., Luo T., Jiang Y. GSK3 protein positively regulates type I insulin-like growth factor receptor through forkhead transcription factors FOXO1/3/4. J. Biol. Chem. 2014, 289:24759-24770.
96. Himpel S., Tegge W., Frank R., Leder S., Joost H.G., Becker W. Specificity determinants of substrate recognition by the protein kinase DYRK1A. J. Biol. Chem. 2000, 275:2431-2438.
97. Aranda S., Laguna A., de la Luna S. DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles. FASEB J. 2011, 25:449-462.
98. Woods Y.L., Rena G., Morrice N., Barthel A., Becker W., Guo S., Unterman T.G., Cohen P. The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem. J. 2001, 355:597-607.
99. Bain J., McLauchlan H., Elliott M., Cohen P. The specificities of protein kinase inhibitors: an update. Biochem. J. 2003, 371:199-204.
100. Obsil T., Obsilova V. Structure/function relationships underlying regulation of FOXO transcription factors. Oncogene 2008, 27:2263-2275.
101. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., Tran H., Ross S.E., Mostoslavsky R., Cohen H.Y., Hu L.S., Cheng H.L., Jedrychowski M.P., Gygi S.P., Sinclair D.A., Alt F.W., Greenberg M.E. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004, 303:2011-2015.
102. Daitoku H., Hatta M., Matsuzaki H., Aratani S., Ohshima T., Miyagishi M., Nakajima T., Fukamizu A. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10042-10047.
103. Motta M.C., Divecha N., Lemieux M., Kamel C., Chen D., Gu W., Bultsma Y., McBurney M., Guarente L. Mammalian SIRT1 represses forkhead transcription factors. Cell 2004, 116:551-563.
104. Frescas D., Valenti L., Accili D. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J. Biol. Chem. 2005, 280:20589-20595.
105. Perrot V., Rechler M.M. The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription. Mol. Endocrinol. 2005, 19:2283-2298.
106. Jing E., Gesta S., Kahn C.R. SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab. 2007, 6:105-114.
107. Nakae J., Oki M., Cao Y. The FoxO transcription factors and metabolic regulation. FEBS Lett. 2008, 582:54-67.
108. Matsuzaki H., Daitoku H., Hatta M., Aoyama H., Yoshimochi K., Fukamizu A. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11278-11283.
109. Dansen T.B., Smits L.M., van Triest M.H., de Keizer P.L., van Leenen D., Koerkamp M.G., Szypowska A., Meppelink A., Brenkman A.B., Yodoi J., Holstege F.C., Burgering B.M. Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat. Chem. Biol. 2009, 5:664-672.
110. Rodgers J.T., Lerin C., Haas W., Gygi S.P., Spiegelman B.M., Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005, 434:113-118.
111. Nasrin N., Ogg S., Cahill C.M., Biggs W., Nui S., Dore J., Calvo D., Shi Y., Ruvkun G., Alexander-Bridges M.C. DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:10412-10417.
112. Mahmud D.L., Deb M.G.A., Platanias D.K., Uddin L.C., Wickrema S. Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells. Oncogene 2002, 21:1556-1562.
113. Spiegelman B.M., Heinrich R. Biological control through regulated transcriptional coactivators. Cell 2004, 119:157-167.
114. Fukuoka M., Daitoku H., Hatta M., Matsuzaki H., Umemura S., Fukamizu A. Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation. Int. J. Mol. Med. 2003, 12:503-508.
115. van der Horst A., de Vries-Smits A.M., Brenkman A.B., van Triest M.H., van den Broek N., Colland F., Maurice M.M., Burgering B.M. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat. Cell Biol. 2006, 8:1064-1073.
116. Wang F., Chan C.H., Chen K., Guan X., Lin H.K., Tong Q. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation. Oncogene 2012, 31:1546-1557.
117. Huang H., Regan K.M., Wang F., Wang D., Smith D.I., van Deursen J.M., Tindall D.J. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:1649-1654.
118. Storz P. Forkhead homeobox type O transcription factors in the responses to oxidative stress. Antioxid. Redox Signal. 2011, 14:593-605.
119. Stone J.R., Yang S. Hydrogen peroxide: a signaling messenger. Antioxid. Redox Signal. 2006, 8:243-270.
120. Zschauer T.C., Matsushima S., Altschmied J., Shao D., Sadoshima J., Haendeler J. Interacting with thioredoxin-1 - disease or no disease?. Antioxid. Redox Signal. 2013, 18:1053-1062.
121. Putker M., Vos H.R., van Dorenmalen K., de Ruiter H., Duran A.G., Snel B., Burgering B.M., Vermeulen M., Dansen T.B. Evolutionary acquisition of cysteines determines FOXO paralog-specific redox signaling. Antioxid. Redox Signal. 2015, 22:15-28.
122. Imai S., Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell. Biol. 2014, 24:464-471.
123. van der Horst A., Tertoolen L.G., de Vries-Smits L.M., Frye R.A., Medema R.H., Burgering B.M. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J. Biol. Chem. 2004, 279:28873-28879.
124. Tanno M., Kuno A., Yano T., Miura T., Hisahara S., Ishikawa S., Shimamoto K., Horio Y. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J. Biol. Chem. 2010, 285:8375-8382.
125. Alcendor R.R., Gao S., Zhai P., Zablocki D., Holle E., Yu X., Tian B., Wagner T., Vatner S.F., Sadoshima J. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 2007, 100:1512-1521.
126. Hasegawa K., Wakino S., Yoshioka K., Tatematsu S., Hara Y., Minakuchi H., Washida N., Tokuyama H., Hayashi K., Itoh H. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem. Biophys. Res. Commun. 2008, 372:51-56.
127. Hori Y.S., Kuno A., Hosoda R., Horio Y. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. PLoS One 2013, 8:e73875.
128. Kitamura Y.I., Kitamura T., Kruse J.P., Raum J.C., Stein R., Gu W., Accili D. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab. 2005, 2:153-163.
129. Brent M.M., Anand R., Marmorstein R. Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification. Structure 2008, 16:1407-1416.
130. Yang Y., Hou H., Haller E.M. Nicosia SV, Bai W. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J. 2005, 24:1021-1032.
131. Hatta M., Cirillo L.A. Chromatin opening and stable perturbation of core histone:DNA contacts by FoxO1. J. Biol. Chem. 2007, 282:35583-35593.
132. Daitoku H., Sakamaki J., Fukamizu A. Regulation of FoxO transcription factors by acetylation and protein-protein interactions. Biochim. Biophys. Acta 2011, 1813:1954-1960.
133. Gabrielsen J.S., Gao Y., Simcox J.A., Huang J., Thorup D., Jones D., Cooksey R.C., Gabrielsen D., Adams T.D., Hunt S.C., Hopkins P.N., Cefalu W.T., McClain D.A. Adipocyte iron regulates adiponectin and insulin sensitivity. J. Clin. Investig. 2012, 122:3529-3540.
134. Wang F., Nguyen M., Qin F.X., Tong Q. SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 2007, 6:505-514.
135. Wang F., Tong Q. SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma. Mol. Biol. Cell 2009, 20:801-808.
136. Rose G., Dato S., Altomare K., Bellizzi D., Garasto S., Greco V., Passarino G., Feraco E., Mari V., Barbi C., BonaFe M., Franceschi C., Tan Q., Boiko S., Yashin A.I., De Benedictis G. Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp. Gerontol. 2003, 38:1065-1070.
137. Bellizzi D., Rose G., Cavalcante P., Covello G., Dato S., De Rango F., Greco V., Maggiolini M., Feraco E., Mari V., Franceschi C., Passarino G., De Benedictis G. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 2005, 85:258-263.
138. Schwer B., North B.J., Frye R.A., Ott M., Verdin E. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J. Cell Biol. 2002, 158:647-657.
139. Scher M.B., Vaquero A., Reinberg D. SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev. 2007, 21:920-928.
140. Jacobs K.M., Pennington J.D., Bisht K.S., Aykin-Burns N., Kim H.S., Mishra M., Sun L., Nguyen P., Ahn B.H., Leclerc J., Deng C.X., Spitz D.R., Gius D. SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression. Int. J. Biol. Sci. 2008, 4:291-299.
141. Sundaresan N.R., Gupta M., Kim G., Rajamohan S.B., Isbatan A., Gupta M.P. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Investig. 2009, 119:2758-2771.
142. Ni Y.G., Berenji K., Wang N., Oh M., Sachan N., Dey A., Cheng J., Lu G., Morris D.J., Castrillon D.H., Gerard R.D., Rothermel B.A., Hill J.A. Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation 2006, 114:1159-1168.
143. Chiang W.C., Tishkoff D.X., Yang B., Wilson-Grady J., Yu X., Mazer T., Eckersdorff M., Gygi S.P., Lombard D.B., Hsu A.L. C. elegans SIRT6/7 homolog SIR-2.4 promotes DAF-16 relocalization and function during stress. PLoS Genet. 2012, 8:e1002948.
144. Tao R., Xiong X., DePinho R.A., Deng C.X., Dong X.C. FoxO3 transcription factor and Sirt6 deacetylase regulate low density lipoprotein (LDL)-cholesterol homeostasis via control of the proprotein convertase subtilisin/kexin type 9 (Pcsk9) gene expression. J. Biol. Chem. 2013, 288:29252-29259.
145. Tao R., Xiong X., DePinho R.A., Deng C.X., Dong X.C. Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6. J. Lipid Res. 2013, 54:2745-2753.
146. Nowak K., Killmer K., Gessner C., Lutz W. E2F-1 regulates expression of FOXO1 and FOXO3a. Biochim. Biophys. Acta 2007, 1769:244-252.
147. Trimarchi J.M., Lees J.A. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell. Biol. 2002, 3:11-20.
148. Shan B., Lee W.H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 1994, 14:8166-8173.
149. DeGregori J., Leone G., Miron A., Jakoi L., Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:7245-7250.
150. Qin X.Q., Livingston D.M., Kaelin W.G., Adams P.D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:10918-10922.
151. Angelis E., Zhao P., Zhang R., Goldhaber J.I., Maclellan W.R. The role of E2F-1 and downstream target genes in mediating ischemia/reperfusion injury in vivo. J. Mol. Cell. Cardiol. 2011, 51:919-926.
152. Sengupta A., Molkentin J.D., Paik J.H., DePinho R.A., Yutzey K.E. FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress. J. Biol. Chem. 2011, 286:7468-7478.
153. Shats I., Gatza M.L., Liu B., Angus S.P., You L., Nevins J.R. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function. Cancer Res. 2013, 73:6056-6067.
154. Dimri G.P., Itahana K., Acosta M., Campisi J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol. Cell. Biol. 2000, 20:273-285.
155. Nogueira V., Park Y., Chen C.C., Xu P.Z., Chen M.L., Tonic I., Unterman T., Hay N. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 2008, 14:458-470.
156. Xie Q., Peng S., Tao L., Ruan H., Yang Y., Li T.M., Adams U., Meng S., Bi X., Dong M.Q., Yuan Z. E2F transcription factor 1 regulates cellular and organismal senescence by inhibiting Forkhead box O transcription factors. J. Biol. Chem. 2014, 289:34205-34213.
157. Zheng S., Moehlenbrink J., Lu Y.C., Zalmas L.P., Sagum C.A., Carr S., McGouran J.F., Alexander L., Fedorov O., Munro S., Kessler B., Bedford M.T., Yu Q., La Thanque N.B. Arginine methylation-dependent reader-writer interplay governs growth control by E2F-1. Mol. Cell 2013, 52:37-51.
158. Kurinna S., Stratton S.A., Tsai W.W., Akdemir K.C., Gu W., Singh P., Goode T., Darlington G.J., Barton M.C. Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice. Hepatology 2010, 52:1023-1032.
159. Renault V.M., Thekkat P.U., Hoang K.L., White J.L., Brady C.A., Kenzelmann Broz D., Venturelli O.S., Johnson T.M., Oskoui P.R., Xuan Z., Santo E.E., Zhang M.Q., Vogel H., Attardi L.D., Brunet A. The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor. Oncogene 2011, 30:3207-3221.
160. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
161. Trotman L.C., Alimonti A., Scaglioni P.P., Koutcher J.A., Cordon-Cardo C., Pandolfi P.P. Identification of a tumour suppressor network opposing nuclear Akt function. Nature 2006, 441:523-527.
162. Essaghir A., Dif N., Marbehant C.Y., Coffer P.J., Demoulin J.B. The transcription of FOXO genes is stimulated by FOXO3 and repressed by growth factors. J. Biol. Chem. 2009, 284:10334-10342.
163. Zhu W.L., Tong H., Teh J.T., Wang M. Forkhead box protein O3 transcription factor negatively regulates autophagy in human cancer cells by inhibiting forkhead box protein O1 expression and cytosolic accumulation. PLoS One 2014, 9:e115087.
164. Bakker W.J., Harris I.S., Mak T.W. FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2. Mol. Cell 2007, 28:941-953.
165. Samarin J., Wessel J., Cicha I., Kroening S., Warnecke C., Goppelt-Struebe M. FoxO proteins mediate hypoxic induction of connective tissue growth factor in endothelial cells. J. Biol. Chem. 2010, 285:4328-4336.
166. Wondisford A.R., Xiong L., Chang E., Meng S., Meyers D.J., Li M., Cole P.A., He L. Control of Foxo1 gene expression by co-activator P300. J. Biol. Chem. 2014, 289:4326-4333.
167. Lützner N., Kalbacher H., Krones-Herzig A., Rösl F. FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop. PLoS One 2012, 7:e42166.
168. Qin W., Pan J., Qin Y., Lee D.N., Bauman W.A., Cardozo C. Identification of functional glucocorticoid response elements in the mouse FoxO1 promoter. Biochem. Biophys. Res. Commun. 2014, 450:979-983.
169. Berry F.B., Skarie J.M., Mirzayans F., Fortin Y., Hudson T.J., Raymond V., Link B.A., Walter M.A. FOXC1 is required for cell viability and resistance to oxidative stress in the eye through the transcriptional regulation of FOXO1A. Hum. Mol. Genet. 2008, 17:490-505.
170. Shen M., Lin F., Zhang J., Tang Y., Chen W.K., Liu H. Involvement of the up-regulated FoxO1 expression in follicular granulosa cell apoptosis induced by oxidative stress. J. Biol. Chem. 2012, 287:25727-25740.
171. Nakae J., Kitamura T., Kitamura Y., Biggs W.H., Arden K.C., Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell 2003, 4:119-129.
172. Liu G.S., Chan E.C., Higuchi M., Dusting G.J., Jiang F. Redox mechanisms in regulation of adipocyte differentiation: beyond a general stress response. Cells 2012, 1:976-993.
173. Higuchi M., Dusting G.J., Peshavariya H., Jiang F., Hsiao S.T., Chan E.C., Liu G.S. Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and Forkhead box O1 mediated upregulation of antioxidant enzymes. Stem Cells Dev. 2013, 22:878-888.
174. Christian M., Zhang X., Schneider-Merck T., Unterman T.G., Gellersen B., White J.O., Brosens J.J. Cyclic AMP-induced forkhead transcription factor, FKHR, cooperates with CCAAT/enhancer-binding protein beta in differentiating human endometrial stromal cells. J. Biol. Chem. 2002, 277:20825-20832.
175. Labied S., Kajihara T., Madureira P.A., Fusi L., Jones M.C., Higham J.M., Varshochi R., Francis J.M., Zoumpoulidou G., Essafi A., Fernandez de Mattos S., Lam E.W., Brosens J.J. Progestins regulate the expression and activity of the forkhead transcription factor FOXO1 in differentiating human endometrium. Mol. Endocrinol. 2006, 20:35-44.
176. Kajihara T., Jones M., Fusi L., Takano M., Feroze-Zaidi F., Pirianov G., Mehmet H., Ishihara O., Higham J.M., Lam E.W., Brosens J.J. Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization. Mol. Endocrinol. 2006, 20:2444-2455.
177. Takano M., Lu Z., Goto T., Fusi L., Higham J., Francis J., Withey A., Hardt J., Cloke B., Stavropoulou A.V., Ishihara O., Lam E.W., Unterman T.G., Brosens J.J., Kim J.J. Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells. Mol. Endocrinol. 2007, 21:2334-2349.
178. Imae M., Fu Z., Yoshida A., Noguchi T., Kato H. Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16. J. Mol. Endocrinol. 2003, 30:253-262.
179. Furuyama T., Yamashita H., Kitayama K., Higami Y., Shimokawa I., Mori N. Effects of aging and caloric restriction on the gene expression of Foxo1, 3, and 4 (FKHR, FKHRL1, and AFX) in the rat skeletal muscles. Microsc. Res. Tech. 2002, 59:331-334.
180. Zhu X., Hart R., Chang M.S., Kim J.W., Lee S.Y., Cao Y.A., Mock D., Ke E., Saunders B., Alexander A., Grossoehme J., Lin K.M., Yan Z., Hsueh R., Lee J., Scheuermann R.H., Fruman D.A., Seaman W., Subramaniam S., Sternweis P., Simon M.I., Choi S. Analysis of the major patterns of B cell gene expression changes in response to short-term stimulation with 33 single ligands. J. Immunol. 2004, 173:7141-7149.
181. Hinman R.M., Bushanam J.N., Nichols W.A., Satterthwaite A.B. B cell receptor signaling down-regulates forkhead box transcription factor class O 1 mRNA expression via phosphatidylinositol 3-kinase and Bruton's tyrosine kinase. J. Immunol. 2007, 178:740-747.
182. Wang W., Furneaux H., Cheng H., Caldwell M.C., Hutter D., Liu Y., Holbrook N., Gorospe M. HuR regulates p21 mRNA stabilization by UV light. Mol. Cell. Biol. 2000, 20:760-769.
183. Tran H., Maurer F., Nagamine Y. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Mol. Cell. Biol. 2003, 23:7177-7188.
184. Fernau N.S., Fugmann D., Leyendecker M., Reimann K., Grether-Beck S., Galban S., Ale-Agha N., Krutmann J., Klotz L.O. Role of HuR and p38MAPK in ultraviolet B-induced post-transcriptional regulation of COX-2 expression in the human keratinocyte cell line HaCaT. J. Biol. Chem. 2010, 285:3896-3904.
185. Bhattacharyya S.N., Habermacher R., Martine U., Closs E.I., Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006, 125:1111-1124.
186. Song I.S., Tatebe S., Dai W., Kuo M.T. Delayed mechanism for induction of gamma-glutamylcysteine synthetase heavy subunit mRNA stability by oxidative stress involving p38 mitogen-activated protein kinase signaling. J. Biol. Chem. 2005, 280:28230-28240.
187. Abdelmohsen K., Kuwano Y., Kim H.H., Gorospe M. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol. Chem. 2008, 389:243-255.
188. Subbaramaiah K., Marmo T.P., Dixon D.A., Dannenberg A.J. Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR. J. Biol. Chem. 2003, 278:37637-37647.
189. Lafarga V., Cuadrado A., Lopez de Silanes I., Bengoechea R., Fernandez-Capetillo O., Nebreda A.R. p38 Mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Mol. Cell. Biol. 2009, 29:4341-4351.
190. Benoit R.M., Meisner N.C., Kallen J., Graff P., Hemmig R., Cebe R., Ostermeier C., Widmer H., Auer M. The x-ray crystal structure of the first RNA recognition motif and site-directed mutagenesis suggest a possible HuR redox sensing mechanism. J. Mol. Biol. 2010, 397:1231-1244.
191. Li Y., Yu J., Du D., Fu S., Chen Y., Yu F., Gao P. Involvement of post-transcriptional regulation of FOXO1 by HuR in 5-FU-induced apoptosis in breast cancer cells. Oncol. Lett. 2013, 6:156-160.
192. Yu F., Jin L., Yang G., Ji L., Wang F., Lu Z. Post-transcriptional repression of FOXO1 by QKI results in low levels of FOXO1 expression in breast cancer cells. Oncol. Rep. 2014, 31:1459-1465.
193. Yang J., Li T., Gao C., Lv X., Liu K., Song H., Xing Y., Xi T. FOXO1 3'UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity. FEBS Lett. 2014, 588:3218-3224.
194. Lin H., Dai T., Xiong H., Zhao X., Chen X., Yu C., Li J., Wang X., Song L. Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS One 2010, 5:e15797.
195. Wu Z., Sun H., Zeng W., He J., Mao X. Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PLoS One 2012, 7:e45825.
196. Wu L., Li H., Jia C.Y., Cheng W., Yu M., Peng M., Zhu Y., Zhao Q., Dong Y.W., Shao K., Wu A., Wu X.Z. MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett. 2012, 586:1038-1043.
197. Fan C., Liu S., Zhao Y., Han Y., Yang L., Tao G., Li Q., Zhang L. Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1. Biomed. Pharmacother. 2013, 67:521-526.
198. Ling N., Gu J., Lei Z., Li M., Zhao J., Zhang H.T., Li X. microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma. Oncol. Rep. 2013, 30:2111-2118.
199. Tan C., Liu S., Tan S., Zeng X., Yu H., Li A., Bei C., Qiu X. Polymorphisms in microRNA target sites of forkhead box O genes are associated with hepatocellular carcinoma. PLoS One 2015, 10:e0119210.
200. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Oriente F., Kitamura Y., Altomonte J., Dong H., Accili D., Spiegelman B.M. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003, 423:550-555.
201. Sandri M., Lin J., Handschin C., Yang W., Arany Z.P., Lecker S.H., Goldberg A.L., Spiegelman B.M. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16260-16265.
202. Geng T., Li P., Yin X., Yan Z. PGC-1alpha promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice. Am. J. Pathol. 2011, 178:1738-1748.
203. Wilcox C.S., Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol. Rev. 2008, 60:418-469.
204. Yoon H.E., Kim S.J., Kim S.J., Chung S., Shin S.J. Tempol attenuates renal fibrosis in mice with unilateral ureteral obstruction: the role of PI3K-Akt-FoxO3a signaling. J. Korean Med. Sci. 2014, 29:230-237.
205. Chung H.W., Lim J.H., Kim M.Y., Shin S.J., Chung S., Choi B.S., Kim H.W., Kim Y.S., Park C.W., Chang Y.S. High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARalpha-FoxO3a-PGC-1alpha pathway. Nephrol. Dial. Transplant. 2012, 27:2213-2225.
206. Exil V., Ping L., Yu Y., Chakraborty S., Caito S.W., Wells K.S., Karki P., Lee E., Aschner M. Activation of MAPK and FoxO by manganese (Mn) in rat neonatal primary astrocyte cultures. PLoS One 2014, 9:e94753.
207. Olmos Y., Valle I., Borniquel S., Tierrez A., Soria E., Lamas S., Monsalve M. Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes. J. Biol. Chem. 2009, 284:14476-14484.
208. Liu X., Greer C., Secombe J. KDM5 interacts with Foxo to modulate cellular levels of oxidative stress. PLoS Genet. 2014, 10:e1004676.
209. Araujo J., Breuer P., Dieringer S., Krauss S., Dorn S., Zimmermann K., Pfeifer A., Klockgether T., Wuellner U., Evert B.O. FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3. Hum. Mol. Genet. 2011, 20:2928-2941.
210. Scherz-Shouval R., Shvets E., Fass E., Shorer H., Gil L., Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 2007, 26:1749-1760.
211. Mizushima N. Autophagy: process and function. Genes Dev. 2007, 21:2861-2873.
212. Hariharan N., Maejima Y., Nakae J., Paik J., Depinho R.A., Sadoshima J. Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ. Res. 2010, 107:1470-1482.
213. Mammucari C., Milan G., Romanello V., Masiero E., Rudolf R., Del Piccolo P., Burden S.J., Di Lisi R., Sandri C., Zhao J., Goldberg A.L., Schiaffino S., Sandri M. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 2007, 6:458-471.
214. Lee D., Goldberg A.L. SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth. J. Biol. Chem. 2013, 288:30515-30526.
215. Zhao Y., Yang J., Liao W., Liu X., Zhang H., Wang S., Wang D., Feng J., Yu L., Zhu W.G. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat. Cell Biol. 2010, 12:665-675.
216. Peserico A., Chiacchiera F., Grossi V., Matrone A., Latorre D., Simonatto M., Fusella A., Ryall J.G., Finley L.W., Haigis M.C., Villani G., Puri P.L., Sartorelli V., Simone C. A novel AMPK-dependent FoxO3A-SIRT3 intramitochondrial complex sensing glucose levels. Cell. Mol. Life Sci. 2013, 70:2015-2029.
217. Chen I.C., Chiang W.F., Chen P.F., Chiang H.C. STRESS-responsive deacetylase SIRT3 is up-regulated by areca nut extract-induced oxidative stress in human oral keratinocytes. J. Cell. Biochem. 2014, 115:328-339.
218. Tseng A.H., Shieh S.S., Wang D.L. SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage. Free Radic. Biol. Med. 2013, 63:222-234.
219. Tseng A.H., Wu L.H., Shieh S.S., Wang D.L. SIRT3 interactions with FOXO3 acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia. Biochem. J. 2014, 464:157-168.
220. Mercken E.M., Crosby S.D., Lamming D.W., JeBailey L., Krzysik-Walker S., Villareal D.T., Capri M., Franceschi C., Zhang Y., Becker K., Sabatini D.M., de Cabo R., Fontana L. Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile. Aging Cell 2013, 12:645-651.
221. Cristancho A.G., Lazar M.A. Forming functional fat: a growing understanding of adipocyte differentiation. Nat. Rev. Mol. Cell. Biol. 2011, 12:722-734.
222. Ducluzeau P.H., Priou M., Weitheimer M., Flamment M., Duluc L., Iacobazi F., Soleti R., Simard G., Durand A., Rieusset J., Andriantsitohaina R., Malthiery Y. Dynamic regulation of mitochondrial network and oxidative functions during 3T3-L1 fat cell differentiation. J. Physiol. Biochem. 2011, 67:285-296.
223. Lee H., Lee Y.J., Choi H., Ko E.H., Kim J.W. Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J. Biol. Chem. 2009, 284:10601-10609.
224. Rajalin A.M., Micoogullari M., Sies H., Steinbrenner H. Upregulation of the thioredoxin-dependent redox system during differentiation of 3T3-L1 cells to adipocytes. Biol. Chem. 2014, 395:667-677.
225. Kelly T., Yang W., Chen C.S., Reynolds K., He J. Global burden of obesity in 2005 and projections to 2030. Int. J. Obes. (Lond.) 2008, 32:1431-1437.
226. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
227. Rochette L., Zeller M., Cottin Y., Vergely C. Diabetes, oxidative stress and therapeutic strategies. Biochim. Biophys. Acta 2014, 1840:2709-2729.
228. Tiganis T. Reactive oxygen species and insulin resistance: the good, the bad and the ugly. Trends Pharmacol. Sci. 2011, 32:82-89.
229. Tiedge M., Lortz S., Drinkgern J., Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997, 46:1733-1742.
230. Sena C.M., Pereira A.M., Seica R. Endothelial dysfunction - a major mediator of diabetic vascular disease. Biochim. Biophys. Acta 2013, 1832:2216-2231.
231. Nakae J., Biggs W.H., Kitamura T., Cavenee W.K., Wright C.V., Arden K.C., Accili D. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 2002, 32:245-253.
232. Altomonte J., Cong L., Harbaran S., Richter A., Xu J., Meseck M., Dong H.H. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. J. Clin. Investig. 2004, 114:1493-1503.
233. Gross D.N., van den Heuvel A.P., Birnbaum M.J. The role of FoxO in the regulation of metabolism. Oncogene 2008, 27:2320-2336.
234. Wang Y., Zhou Y., Graves D.T. FOXO transcription factors: their clinical significance and regulation. Biomed. Res. Int. 2014, 925350. 2014.
235. Zhang K., Li L., Qi Y., Zhu X., Gan B., DePinho R.A., Averitt T., Guo S. Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice. Endocrinology 2012, 153:631-646.
236. Behl Y., Krothapalli P., Desta T., Roy S., Graves D.T. FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats. Diabetes 2009, 58:917-925.
237. Alblowi J., Kayal R.A., Siqueira M., McKenzie E., Krothapalli N., McLean J., Conn J., Nikolajczyk B., Einhorn T.A., Gerstenfeld L., Graves D.T. High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. Am. J. Pathol. 2009, 175:1574-1585.
238. Kim-Muller J.Y., Zhao S., Srivastava S., Mugabo Y., Noh H.L., Kim Y.R., Madiraju S.R., Ferrante A.W., Skolnik E.Y., Prentki M., Accili D. Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice. Cell Metab. 2014, 20:593-602.
239. Massillon D., Barzilai N., Chen W., Hu M., Rossetti L. Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats. J Biol Chem 1996, 271:9871-9874.
240. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., Adelmant G., Stafford J., Kahn C.R., Granner D.K., Newgard C.B., Spiegelman B.M. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138.
241. Housley M.P., Udeshi N.D., Rodgers J.T., Shabanowitz J., Puigserver P., Hunt D.F., Hart G.W. A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. J. Biol. Chem. 2009, 284:5148-5157.
242. Speckmann B., Sies H., Steinbrenner H. Attenuation of hepatic expression and secretion of selenoprotein P by metformin. Biochem. Biophys. Res. Commun. 2009, 387:158-163.
243. Misu H., Takamura T., Takayama H., Hayashi H., Matsuzawa-Nagata N., Kurita S., Ishikura K., Ando H., Takeshita Y., Ota T., Sakurai M., Yamashita T., Mizukoshi E., Yamashita T., Honda M., Miyamoto K., Kubota T., Kubota N., Kadowaki T., Kim H.J., Lee I.K., Minokoshi Y., Saito Y., Takahashi K., Yamada Y., Takakura N., Kaneko S. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab. 2010, 12:483-495.
244. Zhang W., Hietakangas V., Wee S., Lim S.C., Gunaratne J., Cohen S.M. ER stress potentiates insulin resistance through PERK-mediated FOXO phosphorylation. Genes Dev. 2013, 27:441-449.
245. Haeusler R.A., Hartil K., Vaitheesvaran B., Arrieta-Cruz I., Knight C.M., Cook J.R., Kammoun H.L., Febbraio M.A., Gutierrez-Juarez R., Kurland I.J., Accili D. Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors. Nat. Commun. 2014, 5:5190.
246. Sugita S., Arai Y., Tonooka A., Hama N., Totoki Y., Fujii T., Aoyama T., Asanuma H., Tsukahara T., Kaya M., Shibata T., Hasegawa T. A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma. Am. J. Surg. Pathol. 2014, 38:1571-1576.
247. Xie L., Ushmorov A., Leithauser F., Guan H., Steidl C., Farbinger J., Pelzer C., Vogel M.J., Maier H.J., Gascoyne R.D., Moller P., Wirth T. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. Blood 2012, 119:3503-3511.
248. Korani M., Fallah S., Tehranian A., Nourbakhsh M., Samadikuchaksaraei A., Pour M.S., Maleki J. The evaluation of the FOXO1, KLF9 and YT521 genes expression in human endometrial cancer. Clin. Lab. 2013, 59:483-489.
249. Goto T., Takano M., Hirata J., Tsuda H. The involvement of FOXO1 in cytotoxic stress and drug-resistance induced by paclitaxel in ovarian cancers. Br. J. Cancer 2008, 98:1068-1075.
250. Paik J.H., Kollipara R., Chu G., Ji H., Xiao Y., Ding Z., Miao L., Tothova Z., Horner J.W., Carrasco D.R., Jiang S., Gilliland D.G., Chin L., Wong W.H., Castrillon D.H., DePinho R.A. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 2007, 128:309-323.
251. Qinyu L., Long C., Zhen-dong D., Min-min S., Wei-ze W., Wei-ping Y., Cheng-hong P. FOXO6 promotes gastric cancer cell tumorigenicity via upregulation of C-myc. FEBS Lett. 2013, 587:2105-2111.
252. 2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem. J. 2009, 418:29-37.
253. Sun W., Kalen A.L., Smith B.J., Cullen J.J., Oberley L.W. Enhancing the antitumor activity of adriamycin and ionizing radiation. Cancer Res. 2009, 69:4294-4300.
254. Harris I.S., Blaser H., Moreno J., Treloar A.E., Gorrini C., Sasaki M., Mason J.M., Knobbe C.B., Rufini A., Halle M., Elia A.J., Wakeham A., Tremblay M.L., Melino G., Done S., Mak T.W. PTPN12 promotes resistance to oxidative stress and supports tumorigenesis by regulating FOXO signaling. Oncogene 2014, 33:1047-1054.
255. Wang G.J., Liu G.H., Ye Y.W., Fu Y., Zhang X.F. The role of microRNA-1274a in the tumorigenesis of gastric cancer: accelerating cancer cell proliferation and migration via directly targeting FOXO4. Biochem. Biophys. Res. Commun. 2015, 459:629-635.
256. Mao X.P., Zhang L.S., Huang B., Zhou S.Y., Liao J., Chen L.W., Qiu S.P., Chen J.X. Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer. J. Transl. Med. 2015, 13:86.
257. Kim S.Y., Yoon J., Ko Y.S., Chang M.S., Park J.W., Lee H.E., Kim M.A., Kim J.H., Kim W.H., Lee B.L. Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules. BMC Cancer 2011, 11:264.
258. Pramanik K.C., Fofaria N.M., Gupta P., Srivastava S.K. CBP-mediated FOXO-1 acetylation inhibits pancreatic tumor growth by targeting SirT. Mol. Cancer Ther. 2014, 13:687-698.
259. Peck B., Ferber E.C., Schulze A. Antagonism between FOXO and MYC regulates cellular powerhouse. Front. Oncol. 2013, 3:96.
260. Ferber E.C., Peck B., Delpuech O., Bell G.P., East P., Schulze A. FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression. Cell Death Differ. 2012, 19:968-979.
261. Jensen K.S., Binderup T., Jensen K.T., Therkelsen I., Borup R., Nilsson E., Multhaupt H., Bouchard C., Quistorff B., Kjaer A., Landberg G., Staller P. FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function. EMBO J. 2011, 30:4554-4570.
262. Loguercio C., Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic. Biol. Med. 2003, 34:1-10.
263. Diesen D.L., Kuo P.C. Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis. J. Surg. Res. 2010, 162:95-109.
264. Dey A., Cederbaum A.I. Alcohol and oxidative liver injury. Hepatology 2006, 43:S63-S74.
265. Muriel P. Role of free radicals in liver diseases. Hepatol. Int. 2009, 3:526-536.
266. Tao G.Z., Lehwald N., Jang K.Y., Baek J., Xu B., Omary M.B., Sylvester K.G. Wnt/beta-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3. J. Biol. Chem. 2013, 288:17214-17224.
267. Kim P.J., Plescia J., Clevers H., Fearon E.R., Altieri D.C. Survivin and molecular pathogenesis of colorectal cancer. Lancet 2003, 362:205-209.
268. Tapia J.C., Torres V.A., Rodriguez D.A., Leyton L., Quest A.F. Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:15079-15084.
269. Dehner M., Hadjihannas M., Weiske J., Huber O., Behrens J. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1. J. Biol. Chem. 2008, 283:19201-19210.
270. Tenbaum S.P., Ordonez-Moran P., Puig I., Chicote I., Arques O., Landolfi S., Fernandez Y., Herance J.R., Gispert J.D., Mendizabal L., Aguilar S., Ramon y Cajal S., Schwartz S., Vivancos A., Espin E., Rojas S., Baselga J., Tabernero J., Munoz A., Palmer H.G. beta-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat. Med. 2012, 18:892-901.
271. Yan Y., Lackner M.R. FOXO3a and beta-catenin co-localization: double trouble in colon cancer?. Nat. Med. 2012, 18:854-856.
272. Yamaza H., Komatsu T., Wakita S., Kijogi C., Park S., Hayashi H., Chiba T., Mori R., Furuyama T., Mori N., Shimokawa I. FoxO1 is involved in the antineoplastic effect of calorie restriction. Aging Cell 2010, 9:372-382.
273. Masui K., Tanaka K., Akhavan D., Babic I., Gini B., Matsutani T., Iwanami A., Liu F., Villa G.R., Gu Y., Campos C., Zhu S., Yang H., Yong W.H., Cloughesy T.F., Mellinghoff I.K., Cavenee W.K., Shaw R.J., Mischel P.S. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab. 2013, 18:726-739.
274. Mihaylova M.M., Vasquez D.S., Ravnskjaer K., Denechaud P.D., Yu R.T., Alvarez J.G., Downes M., Evans R.M., Montminy M., Shaw R.J. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 2011, 145:607-621.
275. Senf S.M., Sandesara P.B., Reed S.A., Judge A.R. p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle. Am. J. Physiol. Cell Physiol. 2011, 300:C1490-C1501.
276. Bertaggia E., Coletto L., Sandri M. Posttranslational modifications control FoxO3 activity during denervation. Am. J. Physiol. Cell Physiol. 2012, 302:C587-C596.
277. Beharry A.W., Sandesara P.B., Roberts B.M., Ferreira L.F., Senf S.M., Judge A.R. HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy. J. Cell Sci. 2014, 127:1441-1453.
278. Sandri M., Barberi L., Bijlsma A.Y., Blaauw B., Dyar K.A., Milan G., Mammucari C., Meskers C.G., Pallafacchina G., Paoli A., Pion D., Roceri M., Romanello V., Serrano A.L., Toniolo L., Larsson L., Maier A.B., Munoz-Canoves P., Musaro A., Pende M., Reggiani C., Rizzuto R., Schiaffino S. Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway. Biogerontology 2013, 14:303-323.
279. Owusu-Ansah E., Song W., Perrimon N. Muscle mitohormesis promotes longevity via systemic repression of insulin signaling. Cell 2013, 155:699-712.
280. Ambrogini E., Almeida M., Martin-Millan M., Paik J.H., Depinho R.A., Han L., Goellner J., Weinstein R.S., Jilka R.L., O'Brien C.A., Manolagas S.C. FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab. 2010, 11:136-146.
281. Rached M.T., Kode A., Xu L., Yoshikawa Y., Paik J.H., Depinho R.A., Kousteni S. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 2010, 11:147-160.
282. Garrett I.R., Boyce B.F., Oreffo R.O., Bonewald L., Poser J., Mundy G.R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J. Clin. Investig. 1990, 85:632-639.
283. Lee N.K., Choi Y.G., Baik J.Y., Han S.Y., Jeong D.W., Bae Y.S., Kim N., Lee S.Y. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005, 106:852-859.
284. Bhatt N.Y., Kelley T.W., Khramtsov V.V., Wang Y., Lam G.K., Clanton T.L., Marsh C.B. Macrophage-colony-stimulating factor-induced activation of extracellular-regulated kinase involves phosphatidylinositol 3-kinase and reactive oxygen species in human monocytes. J. Immunol. 2002, 169:6427-6434.
285. Manolagas S.C. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr. Rev. 2010, 31:266-300.
286. 2 accumulation. Nat. Commun. 2014, 5:3773.
287. Akasaki Y., Hasegawa A., Saito M., Asahara H., Iwamoto Y., Lotz M.K. Dysregulated FOXO transcription factors in articular cartilage in aging and osteoarthritis. Osteoarthr. Cartil. 2014, 22:162-170.
288. Akasaki Y., Alvarez-Garcia O., Saito M., Carames B., Iwamoto Y., Lotz M.K. FoxO transcription factors support oxidative stress resistance in human chondrocytes. Arthritis Rheumatol. 2014, 66:3349-3358.
289. Jallali N., Ridha H., Thrasivoulou C., Underwood C., Butler P.E., Cowen T. Vulnerability to ROS-induced cell death in ageing articular cartilage: the role of antioxidant enzyme activity. Osteoarthrit. Cartil. 2005, 13:614-622.
290. Renault V.M., Rafalski V.A., Morgan A.A., Salih D.A., Brett J.O., Webb A.E., Villeda S.A., Thekkat P.U., Guillerey C., Denko N.C., Palmer T.D., Butte A.J., Brunet A. FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell 2009, 5:527-539.
291. Paik J.H., Ding Z., Narurkar R., Ramkissoon S., Muller F., Kamoun W.S., Chae S.S., Zheng H., Ying H., Mahoney J., Hiller D., Jiang S., Protopopov A., Wong W.H., Chin L., Ligon K.L., DePinho R.A. FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis. Cell Stem Cell 2009, 5:540-553.
292. Neri C. Role and therapeutic potential of the pro-longevity factor FOXO and its regulators in neurodegenerative disease. Front. Pharmacol. 2012, 3:15.
293. Tothova Z., Kollipara R., Huntly B.J., Lee B.H., Castrillon D.H., Cullen D.E., McDowell E.P., Lazo-Kallanian S., Williams I.R., Sears C., Armstrong S.A., Passegue E., DePinho R.A., Gilliland D.G. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007, 128:325-339.
294. Wang X., Wang Z., Chen Y., Huang X., Hu Y., Zhang R., Ho M.S., Xue L. FoxO mediates APP-induced AICD-dependent cell death. Cell Death Dis. 2014, 5:e1233.
295. Belanger M., Magistretti P.J. The role of astroglia in neuroprotection. Dialogues Clin. Neurosci. 2009, 11:281-295.
296. Owusu-Ansah E., Banerjee U. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 2009, 461:537-541.
297. Tsuchiya K., Westerterp M., Murphy A.J., Subramanian V., Ferrante A.W., Tall A.R., Accili D. Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice. Circ. Res. 2013, 112:992-1003.
298. Mortuza R., Chen S., Feng B., Sen S., Chakrabarti S. High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS One 2013, 8:e54514.
299. Zhang S., Zhao Y., Xu M., Yu L., Zhao Y., Chen J., Yuan Y., Zheng Q., Niu X. FoxO3a modulates hypoxia stress induced oxidative stress and apoptosis in cardiac microvascular endothelial cells. PLoS One 2013, 8:e80342.
300. Yiu W.H., Mead P.A., Jun H.S., Mansfield B.C., Chou J.Y. Oxidative stress mediates nephropathy in type Ia glycogen storage disease. Lab. Investig. 2010, 90:620-629.
301. Lu Q., Zhai Y., Cheng Q., Liu Y., Gao X., Zhang T., Wei Y., Zhang F., Yin X. The Akt-FoxO3a-manganese superoxide dismutase pathway is involved in the regulation of oxidative stress in diabetic nephropathy. Exp. Physiol. 2013, 98:934-945.
302. Ponugoti B., Xu F., Zhang C., Tian C., Pacios S., Graves D.T. FOXO1 promotes wound healing through the up-regulation of TGF-beta1 and prevention of oxidative stress. J. Cell Biol. 2013, 203:327-343.
303. Ponugoti B., Dong G., Graves D.T. Role of forkhead transcription factors in diabetes-induced oxidative stress. Exp. Diabetes Res. 2012, 939751.
304. Hanks S.K., Hunter T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 1995, 9:576-596.
305. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science 2002, 298:1912-1934.
306. Pearce L.R., Komander D., Alessi D.R. The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell. Biol. 2010, 11:9-22.
307. Rena G., Guo S., Cichy S.C., Unterman T.G., Cohen P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J. Biol. Chem. 1999, 274:17179-17183.
308. Guo S., Rena G., Cichy S., He X., Cohen P., Unterman T. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J. Biol. Chem. 1999, 274:17184-17192.
309. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
310. Kops G.J., de Ruiter N.D., De Vries-Smits A.M., Powell D.R., Bos J.L., Burgering B.M. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 1999, 398:630-634.
311. Takaishi H., Konishi H., Matsuzaki H., Ono Y., Shirai Y., Saito N., Kitamura T., Ogawa W., Kasuga M., Kikkawa U., Nishizuka Y. Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:11836-11841.
312. Jacobs F.M., van der Heide L.P., Wijchers P.J., Burbach J.P., Hoekman M.F., Smidt M.P. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J. Biol. Chem. 2003, 278:35959-35967.
313. van der Heide L.P., Jacobs F.M., Burbach J.P., Hoekman M.F., Smidt M.P. FoxO6 transcriptional activity is regulated by Thr26 and Ser184, independent of nucleo-cytoplasmic shuttling. Biochem. J. 2005, 391:623-629.
314. Brunet A., Park J., Tran H., Hu L.S., Hemmings B.A., Greenberg M.E. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol. 2001, 21:952-965.
315. Lee J.W., Chen H., Pullikotil P., Quon M.J. Protein kinase A-alpha directly phosphorylates FoxO1 in vascular endothelial cells to regulate expression of vascular cellular adhesion molecule-1 mRNA. J. Biol. Chem. 2011, 286:6423-6432.
316. Kannan N., Neuwald A.F. Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha. Protein Sci. 2004, 13:2059-2077.
317. Clavel S., Siffroi-Fernandez S., Coldefy A.S., Boulukos K., Pisani D.F., Derijard B. Regulation of the intracellular localization of Foxo3a by stress-activated protein kinase signaling pathways in skeletal muscle cells. Mol. Cell. Biol. 2010, 30:470-480.
318. Yuan Z., Becker E.B., Merlo P., Yamada T., DiBacco S., Konishi Y., Schaefer E.M., Bonni A. Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons. Science 2008, 319:1665-1668.
319. Rena G., Woods Y.L., Prescott A.R., Peggie M., Unterman T.G., Williams M.R., Cohen P. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J. 2002, 21:2263-2271.
320. Kim S., Kim Y., Lee J., Chung J. Regulation of FOXO1 by TAK1-Nemo-like kinase pathway. J. Biol. Chem. 2010, 285:8122-8129.
321. Vielhaber E., Virshup D.M. Casein kinase I: from obscurity to center stage. IUBMB Life 2001, 51:73-78.
322. Chow K.T., Timblin G.A., McWhirter S.M., Schlissel M.S. MK5 activates Rag transcription via Foxo1 in developing B cells. J. Exp. Med. 2013, 210:1621-1634.
323. Kress T.R., Cannell I.G., Brenkman A.B., Samans B., Gaestel M., Roepman P., Burgering B.M., Bushell M., Rosenwald A., Eilers M. The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis. Mol. Cell 2011, 41:445-457.
324. Lehtinen M.K., Yuan Z., Boag P.R., Yang Y., Villen J., Becker E.B., DiBacco S., de la Iglesia N., Gygi S., Blackwell T.K., Bonni A. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 2006, 125:987-1001.
325. Hu M.C., Lee D.F., Xia W., Golfman L.S., Ou-Yang F., Yang J.Y., Zou Y., Bao S., Hanada N., Saso H., Kobayashi R., Hung M.C. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004, 117:225-237.
326. So C.W., Cleary M.L. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function. Mol. Cell. Biol. 2002, 22:6542-6552.
327. Wang F., Marshall C.B., Yamamoto K., Li G.Y., Plevin M.J., You H., Mak T.W., Ikura M. Biochemical and structural characterization of an intramolecular interaction in FOXO3a and its binding with p53. J. Mol. Biol. 2008, 384:590-603.
328. Boura E., Silhan J., Herman P., Vecer J., Sulc M., Teisinger J., Obsilova V., Obsil T. Both the N-terminal loop and wing W2 of the forkhead domain of transcription factor Foxo4 are important for DNA binding. J. Biol. Chem. 2007, 282:8265-8275.
329. Obsilova V., Vecer J., Herman P., Pabianova A., Sulc M., Teisinger J., Boura E., Obsil T. 14-3-3 Protein interacts with nuclear localization sequence of forkhead transcription factor FoxO4. Biochemistry 2005, 44:11608-11617.
330. Biggs W.H., Meisenhelder J., Hunter T., Cavenee W.K., Arden K.C. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:7421-7426.
331. Brunet A., Kanai F., Stehn J., Xu J., Sarbassova D., Frangioni J.V., Dalal S.N., DeCaprio J.A., Greenberg M.E., Yaffe M.B. 14-3-3 Transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 2002, 156:817-828.
332. Brownawell A.M., Kops G.J., Macara I.G., Burgering B.M. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol. Cell. Biol. 2001, 21:3534-3546.
333. Pruitt K.D., Brown G.R., Hiatt S.M., Thibaud-Nissen F., Astashyn A., Ermolaeva O., Farrell C.M., Hart J., Landrum M.J., McGarvey K.M., Murphy M.R., O'Leary N.A., Pujar S., Rajput B., Rangwala S.H., Riddick L.D., Shkeda A., Sun H., Tamez P., Tully R.E., Wallin C., Webb D., Weber J., Wu W., DiCuccio M., Kitts P., Maglott D.R., Murphy T.D., Ostell J.M. RefSeq: an update on mammalian reference sequences. Nucleic Acids Res. 2014, 42:D756-D763.